Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NxStage Medical Company Profile (NASDAQ:NXTM)

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $18.75 (26.77% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/30/2014Canaccord GenuityReiterated RatingBuy$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Piper JaffrayBoost Price Target$16.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Canaccord GenuityBoost Price TargetBuy$19.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Canaccord GenuityReiterated RatingBuy$21.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Wells Fargo & Co.DowngradeMarket Perform -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
2/28/2014Jefferies GroupBoost Price Target$13.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014Leerink SwannBoost Price Target$15.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014Canaccord GenuityBoost Price Target$18.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Piper JaffrayLower Price TargetOverweight$16.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Jefferies GroupLower Price TargetBuy$16.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Canaccord GenuityBoost Price TargetBuy$17.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityBoost Price TargetBuy$16.50 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Lazard Capital MarketsDowngradeBuy -> Neutral$16.00ViewTweet This Rating  Share This Rating on StockTwits
6/27/2013Lazard LtdBoost Price TargetBuy$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
5/3/2013Canaccord GenuityLower Price Target$18.00 -> $16.50ViewTweet This Rating  Share This Rating on StockTwits
5/3/2013Feltl & Co.Boost Price TargetHold$11.50 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Canaccord GenuityBoost Price Target$17.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Canaccord GenuityBoost Price Target$17.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Piper JaffrayLower Price TargetOverweight$18.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Feltl & Co.Lower Price TargetHold$13.00 -> $11.50ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012Northland SecuritiesDowngradeOutperform -> Market Perform$18.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012Jefferies GroupLower Price TargetBuy$21.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss NxStage Medical